Epidiolex Trial for Presymptomatic Treatment of Sturge-Weber Syndrome

Epidiolex Trial for Presymptomatic Treatment of Sturge-Weber Syndrome

Conditions: Sturge – Weber Syndrome (SWS)
Interventions: Drug: Epidiolex 100 mg/mL Oral Solution
Sponsors: Johns Hopkins University; Jazz Pharmaceuticals; Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

August 22, 2026Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Comments